PRT 4165, soluble in DMSO and ethanol and insoluble in water, is compounds that target and inhibit the BMI-1 protein, which plays a critical role in cell proliferation and self-renewal, making them potential candidates for cancer therapy.
PRT 4165 can be used to inhibit PRC2 activity, providing insights into epigenetic regulation and cancer.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.